Han Xiao, Ph.D.
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR170014|
Recruitment of First-Time, Tenure-Track Faculty Members
February 15, 2017
One of the forefronts in developing better treatment for cancer is at the interface between synthetic chemistry, molecular biology, and immunology. A researcher at Rice University is combining his skills in all of these areas to modify biological molecules, develop better anti-cancer antibodies, and engineer more efficient immune therapies for cancer.
Chemical biologist Han Xiao was recruited to the Rice University Department of Chemistry from Stanford University, where he was a Life Sciences Research Foundation fellow in cancer immunotherapy. He was recruited in 2017 with the help of a First-Time Tenure-Track Award from CPRIT.